Videos de Experimentos Relacionados
Alergia a la icodextrina es muy común.
Lancet (London, England)
|July 13, 2000
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Belimumab and alopecia areata: No clear safety signal in a multicentre case series and pharmacovigilance analysis.
Annales de dermatologie et de venereologie·2026
Same author
French national protocol for diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in adults and children.
Annales de dermatologie et de venereologie·2025
Same author
Adherence patterns and their determinants among oral isotretinoin initiators.
Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author
Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and management.
Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author
French national protocol for diagnosis and management of epidermal necrolysis in adults (Stevens-Johnson syndrome and toxic epidermal necrolysis).
Annales de dermatologie et de venereologie·2024
Same author
Compliance with the pregnancy prevention program among women initiating isotretinoin treatment between 2014 and 2021: A nationwide cohort study on the French Health Data System (SNDS).
Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026